Shouldn’t Preventing Type 2 Diabetes Also Prevent Its Long-Term Consequences? von Gerstein, Hertzel C.

Volltext

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes von Riddle, Matthew C, Cefalu, William T, Evans, Philip H, Gerstein, Hertzel C, Nauck, Michael A, Oh, William K, Rothberg, Amy E, le Roux, Carel W, Rubino, Francesco, Schauer, Philip, Taylor, Roy, Twenefour, Douglas

Volltext

Real-world studies no substitute for RCTs in establishing efficacy von Gerstein, Hertzel C, McMurray, John, Holman, Rury R

Volltext

Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes von Gerstein, Hertzel C, Sattar, Naveed, Rosenstock, Julio, Ramasundarahettige, Chinthanie, Pratley, Richard, Lopes, Renato D, Lam, Carolyn S.P, Khurmi, Nardev S, Heenan, Laura, Del Prato, Stefano, Dyal, Leanne, Branch, Kelley

Volltext

Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials von Zoungas, Sophia, Prof, Arima, Hisatomi, Prof, Gerstein, Hertzel C, Prof, Holman, Rury R, Prof, Woodward, Mark, Prof, Reaven, Peter, Prof, Hayward, Rodney A, Prof, Craven, Timothy, MSPH, Coleman, Ruth L, MSc, Chalmers, John, Prof

Volltext

Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial von Doehner, Wolfram, Gerstein, Hertzel C, Ried, Janina, Jung, Hyejung, Asbrand, Christian, Hess, Sibylle, Anker, Stefan D

Volltext

Advanced Glycation End Products Predict Loss of Renal Function and High-Risk Chronic Kidney Disease in Type 2 Diabetes von Koska, Juraj, Gerstein, Hertzel C, Beisswenger, Paul J, Reaven, Peter D

Volltext

Dulaglutide slows kidney disease in type 2 diabetes − Author's reply von Gerstein, Hertzel C

Volltext

HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression von Bethel, M. Angelyn, Diaz, Rafael, Castellana, Noelia, Bhattacharya, Indranil, Gerstein, Hertzel C., Lakshmanan, Mark C.

Volltext

Arm and ankle blood pressure indices, and peripheral artery disease, and mortality: a cohort study von Mohammedi, Kamel, Pigeyre, Marie, Bosch, Jackie, Yusuf, Salim, Gerstein, Hertzel C

Volltext

Growth Differentiation Factor 15 as a Novel Biomarker for Metformin von Gerstein, Hertzel C, Pare, Guillaume, Hess, Sibylle, Ford, Rebecca J, Sjaarda, Jennifer, Raman, Kripa, McQueen, Matthew, Lee, ShunFu, Haenel, Heinz, Steinberg, Gregory R

Volltext

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials von Sattar, Naveed, Lee, Matthew M Y, Kristensen, Søren L, Branch, Kelley R H, Del Prato, Stefano, Khurmi, Nardev S, Lam, Carolyn S P, Lopes, Renato D, McMurray, John J V, Pratley, Richard E, Rosenstock, Julio, Gerstein, Hertzel C

Volltext

The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis von Sherifali, Diana, Nerenberg, Kara, Pullenayegum, Eleanor, Cheng, Ji Emmy, Gerstein, Hertzel C

Volltext

How clinically relevant is statin-induced diabetes? von Gerstein, Hertzel C, Pigeyre, Marie

Volltext

Adolescent Obesity and Early-Onset Type 2 Diabetes von Twig, Gilad, Zucker, Inbar, Afek, Arnon, Cukierman-Yaffe, Tali, Bendor, Cole D., Derazne, Estela, Lutski, Miri, Shohat, Tammy, Mosenzon, Ofri, Tzur, Dorit, Pinhas-Hamiel, Orit, Tiosano, Shmuel, Raz, Itamar, Gerstein, Hertzel C., Tirosh, Amir

Volltext

Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial von Gerstein, Hertzel C, Prof, Miller, Michael E, Prof, Ismail-Beigi, Faramarz, Prof, Largay, Joe, PA-C, McDonald, Charlotte, MD, Lochnan, Heather A, MD, Booth, Gillian L, MD

Volltext

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum von Cefalu, William T, Kaul, Sanjay, Gerstein, Hertzel C, Holman, Rury R, Zinman, Bernard, Skyler, Jay S, Green, Jennifer B, Buse, John B, Inzucchi, Silvio E, Leiter, Lawrence A, Raz, Itamar, Rosenstock, Julio, Riddle, Matthew C

Volltext

Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial von Raubenheimer, Peter J., Cushman, William C., Avezum, Alvaro, Basile, Jan, Conget, Ignacio, Dagenais, Gilles, Hoover, Anastasia, Jansky, Petr, Lanas, Fernando, Leiter, Lawrence A., Lopez‐Jaramillo, Patricio, Pogosova, Nana, Probstfield, Jeffrey, Rao‐Melacini, Purnima, Rydén, Lars, Sheu, Wayne H.‐H., Temelkova‐Kurktschiev, Theodora, Gerstein, Hertzel

Volltext

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial von Mellbin, Linda G, Rydén, Lars, Riddle, Matthew C, Probstfield, Jeffrey, Rosenstock, Julio, Díaz, Rafael, Yusuf, Salim, Gerstein, Hertzel C

Volltext

Adipocyte hypertrophy, fatty liver and metabolic risk factors in South Asians: the Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE) von Anand, Sonia S, Tarnopolsky, Mark A, Rashid, Shirya, Schulze, Karleen M, Desai, Dipika, Mente, Andrew, Rao, Sandy, Yusuf, Salim, Gerstein, Hertzel C, Sharma, Arya M

Volltext